Skip to main content

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Human Genomics operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Publication of research articles by Human Genomics is dependent primarily on their scientific validity and coherence as judged by the Editor-in-Chief, Editorial Board, and/or peer reviewers, who will also assess whether the writing is comprehensible and whether the work represents a useful contribution to the field.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.8
    5-year Journal Impact Factor: 4.0
    Source Normalized Impact per Paper (SNIP): 0.875
    SCImago Journal Rank (SJR): 1.199

    Speed 2023
    Submission to first editorial decision (median days): 10
    Submission to acceptance (median days): 91

    Usage 2023
    Downloads: 761,045
    Altmetric mentions: 816